CompletedPhase 2NCT04287985
Safety and Efficacy Study of VIS649 for IgA Nephropathy
Studying Glomerular disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Visterra, Inc.
- Principal Investigator
- Asher Schachter, M.D.Visterra, Inc.
- Intervention
- Dose-Placebo(drug)
- Enrollment
- 155 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2023
Study locations (30)
- Visterra Investigational Site, Birmingham, Alabama, United States
- Visterra Investigational Site, Los Angeles, California, United States
- Visterra Investigational Site, Oxnard, California, United States
- Visterra Investigational Site, Palo Alto, California, United States
- Visterra Investigational Site, Stanford, California, United States
- Visterra Investigational Site, Denver, Colorado, United States
- Visterra Investigational Site, Lawrenceville, Georgia, United States
- Visterra Investigational Site, Baton Rouge, Louisiana, United States
- Visterra Investigational Site, New Orleans, Louisiana, United States
- Visterra Investigational Site, Baltimore, Maryland, United States
- Visterra Investigational Site, Tupelo, Mississippi, United States
- Visterra Investigational Site, New York, New York, United States
- Visterra Investigational Site, Chapel Hill, North Carolina, United States
- Visterra Investigational Site, Columbus, Ohio, United States
- Visterra Investigational Site, Bethlehem, Pennsylvania, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04287985 on ClinicalTrials.govOther trials for Glomerular disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06858319Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.Novartis Pharmaceuticals
- RECRUITINGPHASE4NCT05839314Effect of Huaier Granule on the Treatment of Idiopathic Membranous NephropathyChinese PLA General Hospital
- RECRUITINGNCT05505500Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.University of Michigan
- RECRUITINGNCT04528446The Impact of Glomerular Disorders on Bone Quality and StrengthColumbia University
- RECRUITINGNCT03929887KOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisSeoul National University Hospital
- RECRUITINGNCT02954419IgA Nephropathy Biomarkers Evaluation Study (INTEREST)Sun Yat-sen University
- RECRUITINGPHASE2NCT00977977Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)